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Small minerals make strong bones
 
Selectins with a catch
 
ot content simply with a good fit, 
evolution has apparently designed 
adhesion molecules that stick optimally 
only when tugged upon. This property, 
say Bryan Marshall and Cheng Zhu 
(Georgia Institute of Technology, Atlanta, 
GA), and Tadayuki Yago and Rodger 
McEver (University of Oklahoma, 
Oklahoma City, OK), and colleagues, 
may stop leukocytes and platelets from 
lingering in stagnant backwaters in the 
blood where there is little or no flow.
Blood is a medium dominated by flow 
and shear forces. “If you think flow is 
disruptive, then greater flow should make 
cells roll faster,” says Zhu. “That’s the case at 
the high end, but at the low end it reverses.”
The Georgia Tech group found that this 
effect could be attributed to the behavior 
of individual adhesion molecules such as 
P-selectin and its partner P-selectin glyco-
protein ligand-1 (PSGL-1). Leukocytes 
N
 
But at the nanoscale mineral sizes found in virtually all 
biocomposites, the story is different. “At nanoscale the 
volume is too small, so the strain energy stored in the mineral 
is too small to break the bond,” says Gao. “So the crack will 
not grow—these flaws will not matter.”
Gao says that this principle explains a case of convergent 
evolution: the similarly small sizes of mineral particles in a 
wide range of biocomposites. Nanoscale sizing can also be 
used in making artificial materials. Material processing, he 
says, “is often like cooking,” with lots of experimenting with 
ingredients backed up by little theory. So a principle from 
biology is welcome. He and his colleagues have used the 
nanoscale theory to study a composite coating—made of 
As mineral size decreases (left to right) to reach that found 
in tooth enamel (inset), the fracture resistance increases.
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grains of titanium 
nitrate embedded 
in amorphous silicon 
nitrate—that is 
almost as hard as 
diamond. “That is a 
perfect application 
of this principle,” he 
says.
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mall can also mean strong. Huajian Gao (Max Planck 
Institute for Metals Research, Stuttgart, Germany), Peter 
Fratzl (University of Leoben, Leoben, Austria), and colleagues 
find that the small size of the mineral particles in bone, teeth, 
and nacre (mother-of-pearl) is the key to their strength, and 
that the same principle can be applied to the construction of 
artificial materials.
Bones, teeth, and nacre are all biocomposites. A protein 
matrix absorbs and distributes shocks, but its softness is 
buttressed by hard, embedded minerals. Somehow the resulting 
combination is a material that can be thousands of times less 
susceptible to fracture than the pure mineral.
Fracture of the pure mineral initiates at flaws. “It’s inevi-
S
 
table that a mineral will be flawed,” says Gao. 
“No material is pure. Just from entropic effects 
you will have impurities.” This is especially 
true in biocomposites, where proteins will 
sneak into and disrupt a mineral matrix.
Gao calculated how the fracture strength 
of such a flawed mineral would vary with 
changing crystal thickness. After an insult, 
the amount of energy absorbed by a given 
crystal depends on the crystal’s volume. 
Much of that energy will be concentrated 
at the most serious flaw, perhaps leading to 
its rupture and thus a catastrophic failure.
 
roll along vessel walls when 
their PSGL-1 binds to the 
P-selectin found on acti-
vated endothelial cells.
At high shear forces, 
increasing shear leads to 
decreasing binding life-
time. But the Georgia 
Tech group found that 
this “slip” mode was 
reversed at lower shear 
forces. In this “catch” 
mode, found only below 
a certain limit of shear 
force, binding lifetime 
At low forces, adhesion 
lifetimes increase with 
increasing force.
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increased with increasing shear force.
For the individual binding events 
measured, the catch mode shear forces 
were small—as small as those produced 
by a few molecular motors. But Zhu feels 
that the catch mode is relevant in the real 
world, where the larger shear forces are 
distributed across many 
binding events per cell.
The crystal structure of 
the binding complex does 
not point to an obvious 
catch mechanism, although 
molecular dynamics simu-
lations may yield clues. 
Zhu is also interested in 
exploring the binding 
energy landscapes. Any 
bound state is a kinetic 
trap, so perhaps the force 
both raises the bottom of 
this energy well and, even 
more, elevates the energy barrier blocking 
escape. Or force might make a short lifetime 
exit path inaccessible. Whatever the mech-
anism, the product is a cell that inspects 
closely only when it has a moving target. 
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Calcium goes nuclear
 
fine reticulum that pokes its fingers across the 
nucleus is capable of storing and releasing calcium, 
according to Wihelma Echevarría, Michael Nathanson 
(Yale University, New Haven, CT), and colleagues. The 
physiological activators of the compartment remain 
obscure, but they could potentially induce localized 
signaling in the nucleus.
Intranuclear extensions of the ER have been described 
previously, but the Yale group is the first to show that the 
compartment both contains and can release calcium. 
Localized photorelease of inositol 1,4,5-trisphosphate 
(InsP
 
3
 
) in the nucleus resulted in a gradient of calcium 
A
Nuclear calcium transients 
send PKC to the nuclear 
envelope (top right) rather 
than the plasma mem-
brane (bottom right).
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that spread from the site of photorelease across the nucleus. The effects of nuclear 
calcium release were distinct from those of cytosolic calcium release: nuclear calcium 
caused translocation of a labeled protein kinase C (PKC) to the nuclear envelope, 
whereas cytosolic calcium triggered PKC translocation to the plasma membrane.
Several growth factor receptors are known to translocate to and signal in the 
nucleus. And several transcription factors—targets of signal transduction pathways—
rely on calcium as one of their stimulatory inputs. As yet there is no obvious candidate 
pathway that combines both of these characteristics. But, if such a pathway is identified, 
two important factors—the site of calcium release and the proximity of target genes 
to this site—may help control the strength of the pathway’s output. 
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A graveyard for mRNA
 
nother day, another organelle. 
Cytoplasmic foci of various mRNA 
processing enzymes have now been 
confirmed by Ujwal Sheth and Roy 
Parker (University of Arizona, Tucson, 
AZ) as functional sites for degrading 
mRNA. But that confirmation has led 
to a host of questions about the origins 
and range of functions of these processing 
bodies (P bodies).
Sheth and Parker found that mRNA 
decapping enzymes, activators of 
decapping, and an mRNA nuclease all 
clustered in two to three P bodies per 
budding yeast cell. The P bodies melted 
away when mRNA turnover was inhibited 
before decapping (by inhibiting deadenyl-
ation), but proliferated when the inhibition 
was at or after the decapping step. Finally, 
a decay intermediate was localized to 
P bodies.
A
 
The range of reactions occurring in the 
P bodies remains to be explored, as does 
the significance of the structure. 
“Whether the [degradation] biochemistry 
requires the macroscopic environment 
[of the P body] or can occur in a dispersed 
fashion is not known,” says Parker.
A full understanding of P body control 
is also hampered by the field’s poor grip 
on what controls the switches between 
different mRNA states: from active trans-
lation to storage or destruction. At least 
one factor implicated in storage is found 
in the P bodies, so these bodies may do 
double duty in storage and destruction. 
At the very least, says Parker, the P bodies 
sequester mRNAs that are being degraded, 
so they do not compete for factors with 
mRNAs that are being actively translated. 
Determining how much additional regu-
lation is present is work for the future.
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P bodies proliferate when mRNA degra-
dation is blocked (right).
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Metastasizing in search of oxygen
 
etastatic growth can start when suffocating tumor cells go hunting for 
oxygen, according to a report from Selma Pennacchietti, Paolo Michieli, 
Paolo Comoglio, and colleagues (University of Torino, Torino, Italy).
The response appears to be part of a normal program used to create and 
maintain organs—a process that uses oxygen gradients as one guiding principle. 
“Mother Nature has given us the invasion program not to promote metastasis 
but to promote sprouting and branching of epithelial tubes,” says Comoglio.
In hypoxic tumor cells, his team found that binding of hypoxia inducible 
factor-1 (HIF-1) to two sites in the 
 
met
 
 promoter-induced expression of the 
Met tyrosine kinase receptor. This newly abundant Met, after the binding of 
ubiquitous hepatocyte growth factor (HGF, or scatter factor-1), activates an 
invasive migration program.
They found that Met levels were 
dramatically increased in the hypoxic 
areas of tumors, and that high levels of 
Met were both necessary for hypoxia-
induced branching morphogenesis and 
sufficient to induce branching morpho-
genesis in normoxic conditions.
Previous workers have stressed that 
hypoxia induces angiogenesis and 
apoptosis resistance. But the new work suggests that treatment with anti-
angiogenic agents is too simplistic. These drugs increase hypoxia in a 
tumor, and may thus promote metastasis. A combination therapy that 
attacks both angiogenic and metastatic pathways may have a better chance 
of success.
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M
The proinvasive effect of HGF (left) 
is amplified by hypoxia (right).
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